Citation Tools
PDFTherapeutics/Prevention
Randomised controlled trial
Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes